10. Emzor Pharmaceutical Industries
- Headquarters: Lagos, Nigeria
- Key Focus Areas: Analgesics, Antimalarials, Pediatric Formulations, Active Pharmaceutical Ingredients (APIs)
- Estimated Annual Revenue: ~$100M – $130M
Emzor Pharmaceutical Industries stands as West Africa’s most iconic domestic drug manufacturer. Founded by Dr. Stella Okoli, Emzor manufactures over 140 healthcare products, with its flagship Emzor Paracetamol holding a near-ubiquitous presence in Nigerian households.
9. Universal Corporation Limited (UCL)
- Headquarters: Kikuyu, Kenya
- Key Focus Areas: Antiretrovirals (ARVs), Antimalarials, Antibiotics, Essential Generics
- Estimated Annual Revenue: ~$110M – $140M
Universal Corporation Limited (UCL) represents East Africa's manufacturing hub. As one of the few pharmaceutical manufacturing plants in Sub-Saharan Africa to earn WHO prequalification for key formulations, UCL plays a key role in supply security for East and Central Africa.
8. Laprophan
- Headquarters: Casablanca, Morocco
- Key Focus Areas: Gastrointestinal, Anti-inflammatory, Central Nervous System (CNS), OTC Medicines
- Estimated Annual Revenue: ~$200M – $250M
A pioneer in North African pharmaceuticals, Laprophan has operated in Morocco for over seven decades. Unlike pure contract packagers, Laprophan has developed a strong R&D culture, holding numerous national and international patents for innovative formulations and drug delivery mechanisms.
7. Biopharm SPA
- Headquarters: Algiers, Algeria
- Key Focus Areas: Cardiovascular, Metabolic Health, Generics, Contract Manufacturing
- Estimated Annual Revenue: ~$300M – $350M
Biopharm SPA is a vertically integrated pharmaceutical force in North Africa, combining domestic manufacturing, logistics, and wholesale distribution. Listed on the Algiers Stock Exchange, the group operates state-of-the-art production sites that adhere to strict European Good Manufacturing Practices (EU-GMP).
6. Saidal Group
- Headquarters: Algiers, Algeria
- Key Focus Areas: Essential Generics, Insulin, Vaccines, Cardiovascular Drugs
- Estimated Annual Revenue: ~$320M – $360M
Saidal Group is Algeria's state-backed pharmaceutical titan. Established to guarantee national health sovereignty, Saidal operates multiple specialized industrial sites across Algeria.
5. EIPICO (Egyptian International Pharmaceutical Industries Co.)
- Headquarters: 10th of Ramadan City, Egypt
- Key Focus Areas: Antibiotics, Ophthalmic Drops, Injectables, Cephalosporins
- Estimated Annual Revenue: ~$350M – $400M
EIPICO is Egypt’s largest pharmaceutical exporter, supplying drugs to over 65 countries across Africa, Asia, and Eastern Europe. Operating tens of specialized production lines, EIPICO holds a dominant share of the Egyptian market for sterile injectables, ophthalmics, and antibiotics.
4. Adcock Ingram Holdings
- Headquarters: Midrand, South Africa
- Key Focus Areas: Critical Care, Hospital Products, Over-The-Counter (OTC) Brands, Generics
- Estimated Annual Revenue: ~$480M – $530M
With roots dating back to 1890, Adcock Ingram is one of South Africa's oldest and most deeply rooted healthcare companies. The company holds a commanding market position in South Africa's private OTC segment and is the premier provider of high-volume parenteral solutions (intravenous fluids) and blood-banking products to the public hospital system.
3. EVA Pharma
- Headquarters: Giza, Egypt
- Key Focus Areas: Oncology, Vaccines, Immunosuppressants, Diabetes Care, Neurosciences
- Estimated Annual Revenue: ~$500M – $550M
EVA Pharma is one of the fastest-growing pharmaceutical companies in the Middle East and Africa (MEA) region. Operating multiple state-of-the-art manufacturing facilities, the company produces over a million healthcare units daily.
2. Pharco Corporation
- Headquarters: Alexandria, Egypt
- Key Focus Areas: Hepatology (Hepatitis C), Anti-infectives, Cardiology, Mass Generics
- Estimated Annual Revenue: ~$600M – $700M
Pharco Corporation is a powerhouse in North African healthcare, comprising multi-subsidiary manufacturing facilities near Alexandria. Pharco gained international recognition for its pivotal role in Egypt's historic campaign to eradicate Hepatitis C, producing ultra-low-cost, high-efficacy antiviral generics locally.
1. Aspen Pharmacare Holdings
- Headquarters: Durban, South Africa
- Key Focus Areas: Injectables, Anaesthetics, Antiretrovirals, Vaccines, Complex Generics
- Estimated Annual Revenue: ~$2.2B – $2.5B
Uncontested at the top spot is Aspen Pharmacare, Africa’s largest pharmaceutical manufacturer and a major player in the global generic and sterile injectable markets. Aspen’s world-class manufacturing site in Gqeberha, South Africa, boasts advanced sterile manufacturing capabilities, producing sophisticated biological products, complex vaccines, and anesthetics for global markets.
